Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph phase_1
4
67%
Ph phase_2
2
33%

Phase Distribution

4

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
4(66.7%)
Phase 2Efficacy & side effects
2(33.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Other(6)

Detailed Status

unknown6

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
N/A
Most Advanced
Phase 2

Trials by Phase

Phase 14 (66.7%)
Phase 22 (33.3%)

Trials by Status

unknown6100%

Recent Activity

0 active trials
Showing 5 of 6
unknownphase_1

SCT200 in Combination With SCT-I10A/Paclitaxel/Docetaxel in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

NCT05552807
unknownphase_2

SCT200 Plus Platinum-based Chemotherapy in Head and Neck Squamous Cell Carcinoma

NCT03874741
unknownphase_1

Study of SCT-I10A Combined SCT200 or SCT-I10A Combined SCT200 Plus Chemotherapy in ESCC and CRC

NCT04229537
unknownphase_1

Efficacy and Safety of SCT200 in Patients With Advanced Squamous Non-small Cell Lung Cancer

NCT03808701
unknownphase_1

Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of SCT200 in Patients With Advanced Solid Tumors

NCT03692520
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT05552807Phase 1

SCT200 in Combination With SCT-I10A/Paclitaxel/Docetaxel in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Unknown
NCT03874741Phase 2

SCT200 Plus Platinum-based Chemotherapy in Head and Neck Squamous Cell Carcinoma

Unknown
NCT04229537Phase 1

Study of SCT-I10A Combined SCT200 or SCT-I10A Combined SCT200 Plus Chemotherapy in ESCC and CRC

Unknown
NCT03808701Phase 1

Efficacy and Safety of SCT200 in Patients With Advanced Squamous Non-small Cell Lung Cancer

Unknown
NCT03692520Phase 1

Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of SCT200 in Patients With Advanced Solid Tumors

Unknown
NCT03692689Phase 2

Safety and Efficacy of SCT200 in Patients With Relapsed or Metastatic Triple Receptor Negative Breast Cancer

Unknown

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6